0000784199-23-000052.txt : 20230301
0000784199-23-000052.hdr.sgml : 20230301
20230301184145
ACCESSION NUMBER: 0000784199-23-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230301
DATE AS OF CHANGE: 20230301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maney Rochelle L.
CENTRAL INDEX KEY: 0001850597
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13165
FILM NUMBER: 23695634
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BLVD, NW
CITY: KENNESAW
STATE: GA
ZIP: 30144
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARTIVION, INC.
CENTRAL INDEX KEY: 0000784199
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 592417093
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
BUSINESS PHONE: 7704193355
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOLIFE INC
DATE OF NAME CHANGE: 19940526
4
1
wf-form4_167771408921807.xml
FORM 4
X0306
4
2023-02-23
0
0000784199
ARTIVION, INC.
AORT
0001850597
Maney Rochelle L.
1655 ROBERTS BLVD., NW
KENNESAW
GA
30144
0
1
0
0
VP, Quality
Common Stock
2023-02-23
4
A
0
2356
0
A
25895
D
Common Stock
2023-02-27
4
S
0
878
12.938
D
25017
D
Common Stock
2023-02-23
4
A
0
4240
0
A
29257
D
Common Stock
2023-02-27
4
A
0
790
12.938
D
28467
D
Common Stock
2023-02-28
4
S
0
406
13.236
D
28061
D
Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.
These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
/s/ Rochelle Maney
2023-02-28